Format

Send to

Choose Destination
World J Gastroenterol. 2006 Apr 21;12(15):2363-8.

Biological role of surface Toxoplasma gondii antigen in development of vaccine.

Author information

1
Shandong Institute of Parasitic Diseases, Jining Taibai Zhong Road #11, Jining 272033, Shandong Province, China. keyiliu2003@yahoo.com

Abstract

AIM:

To analyze the biological role of the surface antigen of Toxoplasma gondii (T gondii) in development of vaccine.

METHODS:

The surface antigen of T gondii (SAG1) was expressed in vitro. The immune response of the host to the antigen was investigated by detection of specific antibody reaction to SAG1 and production of cytokines. Mice were immunized with recombinant SAG1 and challenged with lethal strain of T gondii RH. The monoclonal antibody to r-SAG1 was prepared and used to study the effects of SAG1 on T gondii tachyzoites under electromicroscope.

RESULTS:

The mice immunized with recombinant SAG1 delayed death for 60 h compared to the control group. The recombinant SAG1 induced specific high titer of IgG and IgM antibodies as well as IFN-gamma, IL-2 and IL-4 cytokines in mice. In contrast, IL-12, IL-6 and TNF-alpha were undetectable. When T gondii tachyzoites were treated with the monoclonal antibody to r-SAG1, the parasites were gathered together, destroyed, deformed, swollen, and holes and gaps formed on the surface.

CONCLUSION:

SAG1 may be an excellent vaccine candidate against T gondii. The immune protection induced by SAG1 against T gondii may be regulated by both hormone- and cell-mediated immune response.

PMID:
16688826
PMCID:
PMC4088071
DOI:
10.3748/wjg.v12.i15.2363
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
Loading ...
Support Center